The shift toward decentralized healthcare and rapid diagnostic accuracy is fueling a massive expansion in the medical testing sector. The Molecular Point-of-Care Testing (Using NAAT) Market was valued at USD 36.42 billion in 2024 and is projected to reach USD 86.59 billion by 2032, growing at an impressive CAGR of 14.91% from 2025 to 2032. This growth...